Director’s Innovation Awards Presented at the NCI PI Retreat
r.
John Niederhuber, Acting Director, NCI, presented the 2006 Director’s Innovation
Awards to recipients at an award ceremony held during the NCI Intramural Scientific
Retreat on January 11. I worked closely with Drs. von Eschenbach and Niederhuber
to develop this award program as a means to stimulate highly innovative proposals
on cancer-related research problems from our junior staff. Based on the overwhelming
response and the high quality of proposals received, it is clear that the program
was a success, and is therefore likely to be repeated in the future. Of the
120 applicants in this round from CCR, 8 awards at the PI level (up to $50,000)
and 20 awards at the Career Development level (up to $10,000) were presented.
Please join with me in congratulating the recipients on their outstanding achievement.
Robert Wiltrout, PhD
Director
PI Award Recipients:
Mirit Aladjem, PhD, Laboratory of Molecular Pharmacology,
CCR
Single Molecule Studies of Replication Dynamics in Normal
and Cancer Cells
Daniel Fowler, MD, PhD, Experimental Transplantation
and Immunology Branch, CCR
Allograft T-cell Engineering for Therapy of Metastatic Renal
Cell Carcinoma
Jeffrey Gildersleeve, PhD, Laboratory of Medicinal Chemistry,
CCR
Application of Carbohydrate Microarrays to Cancer and HIV
Vaccine Development
Mikhail Kashlev, PhD, Gene Regulation and Chromosome
Biology Laboratory, CCR
Nanobiochemistry: Monitoring of Basic Biochemical Processes
Javed Khan, MD, Pediatric Oncology Branch, CCR
Sensitive and Specific Detection of miRNA Using Luminex Beads
and Locked Nucleic Acid
Stan Lipkowitz, MD, PhD, Laboratory of Cellular and
Molecular Biology, CCR
Identification of Molecular Targets in ER-Negative, PR-Negative,
and HER2/Neu-Negative Breast Cancer
Andre Nussenzweig, PhD, Experimental Immunology Branch,
CCR
Mechanisms of Cancer-associated Chromosomal Translocations
Ying Zhang, PhD, Laboratory of Cellular and Molecular
Biology, CCR
Smad3 Adenovirus as a Novel Cancer Therapeutic Treatment for
Hepatocellular Carcinoma
Career Development Award Recipients:
Praveen Arany, PhD, Postdoctoral Fellow, Laboratory
of Cell Regulation and Carcinogenesis, CCR
Wound Matrix as a Paradigm for Modeling the Cancer Microenvironment
Katherine Calvo, MD, PhD, Clinical Fellow, Laboratory
of Pathology, CCR
Real-time In Vivo Proteomic Profiling of Human Tumors
Perfused with Targeted Inhibitors
Joan L. Cmarik, PhD, Staff Scientist, Laboratory of
Cancer Prevention, CCR
Does Viral Infection Play a Role in Bronchioloalveolar Adenocarcinoma
of the Lung?
Albert Gold, PhD, Staff Scientist, Laboratory of Genomic
Diversity, CCR
Defining Breast Cancer Risk Modifier Genes
Mark Hoenerhoff, PhD, and Hark Kim, MD, PhD, Postdoctoral
Fellows, Laboratory of Cell Regulation and Carcinogenesis, CCR
Creation of Relevant Genetically Engineered Mouse Models for
Gastric Cancer
Cary Hsu, MD, and Richard Morgan, PhD, Surgery Branch,
CCR
Evaluation of Cybr and IL-15 in Leukemogenesis: Applications
for Adoptive Cell Transfer
Su Young Kim, MD, PhD, Postdoctoral Fellow, Pediatric
Oncology Branch, CCR
CXCR4 Determines Dormancy and the Metastatic Phenotype in
Osteosarcoma Cells
Maria Kireeva, PhD, Postdoctoral Fellow, Gene Regulation
and Chromosome Biology Laboratory, CCR
Wound Matrix as a Paradigm for Modeling the Cancer Microenvironment
Juhong Liu, PhD, Staff Scientist, Laboratory of Pathology,
CCR
Survey of p38/JTV Targets Using ChIP-on-chip and Mammalian
Two-hybrid Screening
Philip Lorenzi, PhD, Postdoctoral Fellow, Laboratory
of Molecular Pharmacology, CCR
A New Bioinformatic Approach for Identification of Synergistic
Drug Combinations
Diane Palmieri, PhD, Staff Scientist, Laboratory of
Molecular Pharmacology, CCR
A Novel Use for Lithium as a Treatment for Breast Cancer Brain
Metastases
r.
John Niederhuber, Acting Director, NCI, presented the 2006 Director’s Innovation
Awards to recipients at an award ceremony held during the NCI Intramural Scientific
Retreat on January 11. I worked closely with Drs. von Eschenbach and Niederhuber
to develop this award program as a means to stimulate highly innovative proposals
on cancer-related research problems from our junior staff. Based on the overwhelming
response and the high quality of proposals received, it is clear that the program
was a success, and is therefore likely to be repeated in the future. Of the
120 applicants in this round from CCR, 8 awards at the PI level (up to $50,000)
and 20 awards at the Career Development level (up to $10,000) were presented.
Please join with me in congratulating the recipients on their outstanding achievement.